Income Statement
WHITEHAWK THERAPEUTICS, INC.
WHWK
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
7.15 | 25.98 | 24.35 | 15.22 | 1.12 | 15.00 | 20.00 | 20.16 | - | - | - | - | - | - | - |
|
Cost of Revenue
|
0.76 | 3.02 | 2.81 | 1.34 | 0.84 | - | - | - | - | - | - | - | - | - | - |
|
Gross Profit
|
6.39 | 22.96 | 21.55 | 13.88 | 0.28 | 15.00 | 20.00 | 20.16 | - | - | - | - | - | - | - |
|
Operating Expenses
|
120.79 | 87.78 | 93.48 | 72.84 | 112.34 | 21.36 | 24.44 | 31.34 | 21.39 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
|
Research & Development
|
90.96 | 51.03 | 48.93 | 32.66 | 19.67 | 12.59 | 12.82 | 17.85 | 12.15 | - | - | - | - | - | - |
|
Selling, General & Administrative
|
29.82 | 36.75 | 44.55 | 40.18 | 18.51 | 8.76 | 9.76 | 13.49 | 9.24 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
-114.40 | -64.82 | -71.93 | -58.96 | -112.05 | -6.36 | -4.44 | -11.18 | -21.39 | -0.03 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
|
Non-Operating Income
|
-93.80 | -1.13 | -6.17 | 1.56 | -1.97 | 2.04 | 1.17 | 0.78 | -0.01 | - | - | - | - | - | - |
|
Interest Income
|
6.23 | 3.93 | 6.40 | 2.40 | 0.01 | - | - | - | - | - | - | - | - | - | - |
|
Interest Expense
|
- | - | 0.23 | 0.23 | 0.67 | - | - | - | - | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
|
Other Non-Op Income / Expense
|
93.80 | 3.77 | 6.17 | 2.17 | 1.13 | - | - | - | - | - | - | - | - | - | - |
|
Income Before Tax
|
-20.60 | -63.69 | -65.77 | -60.51 | -110.09 | - | - | - | - | - | - | - | - | - | - |
|
Income Tax Expense
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Net Income
|
-20.60 | -63.69 | -65.77 | -60.51 | -110.09 | -4.32 | -23.27 | -10.40 | -21.40 | -0.04 | -0.03 | -0.03 | -0.03 | -0.03 | -0.03 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-114.32 | -64.63 | -71.76 | -58.80 | -111.95 | -6.36 | -4.44 | -11.18 | -21.39 | -0.03 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
|
Earnings Per Share (Basic)
|
-0.33 | -2.36 | -2.44 | -2.69 | - | - | - | - | - | - | - | - | - | - | - |
|
Diluted EPS
|
-0.33 | -2.36 | -2.44 | -2.69 | - | - | - | - | - | - | - | - | - | - | - |
|
Weighted Average Shares
|
61.89 | 27.03 | 26.92 | 22.51 | - | - | - | - | - | - | - | - | - | - | - |
|
Diluted Weighted Avg Shares
|
61.89 | 27.03 | 26.92 | 22.51 | - | - | - | - | - | - | - | - | - | - | - |
|
Comprehensive Income
|
-20.49 | -63.70 | -65.62 | -60.63 | -110.74 | - | - | - | - | - | - | - | - | - | - |